We are live on ! Find out more
CALT

Calliditas Therapeutics AB American Depositary Shares
CALT

Delisted

CALT was delisted on the 20th of September, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of CALT yet.

CALT Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Calliditas Therapeutics AB American Depositary Shares (CALT) for Q4 2024, worth a combined $0 — down 100% from $750K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CALT and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Crossmark Global Holdings, exiting entirely with an estimated $655K sold.

  • 0 institutional investors held Calliditas Therapeutics AB American Depositary Shares (CALT) as of Q4 2024, down from 5 in Q3 2024.
  • Funds reported $0 of Calliditas Therapeutics AB American Depositary Shares stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Calliditas Therapeutics AB American Depositary Shares positions in Q4 2024 and 5 closed out, a net change of -5 holders.
  • The largest Calliditas Therapeutics AB American Depositary Shares seller in Q4 2024 was Crossmark Global Holdings, an estimated $655K sold.

Based on aggregated 13F filings for Q4 2024.